Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: Implications for the disruption of latent inhibition

Behavioural Pharmacology

Volumn 7, Issue 2, 1996, Pages 119-129

  Warburton, E C ^b   Mitchell, S N ^c   Joseph, M H ^a,d  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Sandoz Pharma Ltd   (Switzerland)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amphetamine sensitisation; Calcium dependence; Dopamine; In vivo dialysis; Latent inhibition; Locomotor activity; Nucleus accumbens; Ondansetron; Rat

Indexed keywords

CALCIUM; DEXAMPHETAMINE; DOPAMINE; MAGNESIUM; ONDANSETRON; SEROTONIN 3 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ANTAGONISM; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT INHIBITION; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SCHIZOPHRENIA; SENSITIZATION;

EID: 0029880731     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Baruch I, Hemsley DR and Gray JA (1988) Differential performance of acute and chronic schizophrenics in a latent inhibition task. Journal of Nervous and Mental Disorders, 176, 598-606.
2. Benwell MEM, Balfour DJK and Lucchi HM (1993) Influence of tetrodoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology, 112, 467-474.
3. Brazell MP, Mitchell SN, Joseph MH and Gray JA (1990) Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology, 29, 1177-1185.
4. Dunn LA, Atwater GE and Kilts CD (1993) Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology, 112, 315-323.
5. Ellison GD and Eison MA (1983) Continuous amphetamine intoxication; an animal model of the acute psychotic episode. Psychological Medicine, 13, 751-762.
6. Feldon J and Weiner I (1991) The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biological Psychiatry, 38, 309-314.
7. Feldon J, Shofel A and Weiner I (1991) Latent inhibition is unaffected by dopamine agonists. Pharmacology Biochemistry and Behavior, 38, 309-314.
8. Gray JA, Feldon J, Rawlins JNP, Hemsley DR and Smith AD (1991) The neuropsychology of schizophrenia. Behavioral and Brain Sciences, 14, 1-20.
9. Gray NS, Hemsley DR and Gray JA (1992a) Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurology, Psychiatry and Brain Research, 1, 83-89.
10. Gray NS, Pickering AD, Hemsley DR, Dawling S and Gray JA (1992b) Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology, 107, 425-430.
11. Guix T, Hurd YL and Ungerstedt U (1992) Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats. Neuroscience Letters, 138, 137-140.
12. ++ dependence of the amphetamine, nomifensine and Lu 19-005 effect on in vivo dopamine transmission. European Journal of Pharmacology, 166, 261-269.
13. Imperato A, Mulas A and Di Chiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. European Journal of Pharmacology, 132, 337-338.
14. Imperato A, Scrocco MG, Bacchi S and Andelucci L (1990) NMDA receptors and in vivo dopamine release in nucleus accumbens and caudatus. European Journal of Pharmacology, 187, 555-556.
15. Joseph MH and Jones SH (1991) Latent inhibition and blocking: further consideration of their construct validity as animal models of schizophrenia. Behavioural Pharmacology, 2, 521-526.
16. Joseph MH, Naylor CGG and Peters SL (1993) Amphetamine disruption of latent inhibition is prevented by haloperidol given only at conditioning, but not at pre-exposure. Journal of Psychopharmacology, Suppl., p. A8.
17. Joseph MH, Peters SL and Gray JA (1993) Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology, 110, 187-192.
18. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurones in the ventral tegmental area. Brain Research Reviews, 18, 75-113.
19. Kalivas PW and Duffy P (1990) Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse, 5, 48-58.
20. Kalivas PW and Duffy P (1993) Time course of extracellular dopamine and behavioural sensitization to cocaine. II. Dopamine perikarya. Journal of Neuroscience, 13, 276-284.
21. Kalivas PW and Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitisation of motor activity. Brain Research Reviews, 16, 223-244.
22. Kalivas PW and Weber B (1988) Amphetamine injection into the A10 dopamine region sensitises to peripheral amphetamine and cocaine. Journal of Pharmacology and Experimental Therapeutics, 245, 1095-1102.
23. Karler R, Turkanis SA, Partlow LM and Calder LD (1991) Calcium channel blockers and behavioural sensitisation. Life Sciences, 49, 165-170.
24. Kelly PH and Iversen SD (1976) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurones: abolition of psychostimulant-induced locomotor activity in rats. European Journal of Pharmacology, 40, 45-56.
25. Killcross AS and Robbins TW (1993) Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology, 110, 479-489.
26. Llinas R, Greenfield SA and Jahnsen H (1984) Electrophysiology of pars compacta cells in the in vitro substantia nigra: a possible mechanism for dendritic release. Brain Research, 249, 127-132.
27. Lubow RE (1989) Latent Inhibition and Conditioned Attention Theory. Cambridge University Press, Cambridge.
28. ++ dependently endogenous DOPA from rat striatal slices. Brain Research, 520, 334-337.
29. Nisell M, Nomikos GG and Svensson TH (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse, 16, 36-44.
30. Peters SL and Joseph MH (1993) Haloperidol potentiation of latent inhibition in rats; evidence for a critical role at conditioning rather than pre-exposure. Behavioural Pharmacology, 4, 183-186.
31. Randrup A and Munkvaad I (1970) Biochemical, anatomical and psychological investigations of stereotyped behaviour induced by amphetamines. In: Amphetamines and Related Compounds (Eds E Costa and S Garattini), pp. 695-713. Raven Press, New York.
32. Robinson TE (1984) Behavioral sensitisation: characterisation of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology, 84, 466-475.
33. Robinson TE and Becker JB (1986) Enduring changes in brain and behaviour produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Research Reviews, 11, 157-198.
34. Robinson TE, Jurson PA, Bennett JA and Bentgen KM (1988) Persistent sensitisation of dopaminergic transmission in the ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Research, 462, 211-222.
35. Seutin V, Verbanck P, Massotte L and Dresse A (1991) Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro. Brain Research, 558, 141-144.
36. Solomon PR, Crider A, Winkelman JW, Tun A, Karner RM and Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biological Psychiatry 16, 519-537
37. Sulzer D, Maidment NT and Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurones. Journal of Neurochemistry, 60, 527-535.
38. Vezina P (1993) Amphetamine injected into the ventral tegmental area sensitises the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Research, 605, 332-337.
39. Warburton EC (1994) 5HT-3 receptor antagonists in animal models of attention: a behavioural and neurochemical study. PhD thesis, Institute of Psychiatry, University of London.
40. Warburton EC, Mitchell SN and Joseph MH (1993) Sensitisation of dopamine release in the accumbens following amphetamine: calcium dependency accompanies altered effects on behavioural function. Behavioural Pharmacology, 4, 454.
41. Warburton EC, Joseph MH, Feldon J, Weiner I and Gray JA (1994) Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology, 114, 657-664.
42. Weiner I (1990) Neural substrates of latent inhibition: the switching model. Psychological Bulletin, 108, 442-461.
43. Weiner I, Feldon J and Katz Y (1987a) Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacology Biochemistry and Behavior, 26, 241-246.
44. Weiner I, Izraeli-Telerant A and Feldon J (1987b) Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine. Psychopharmacology, 91, 345-351.
45. Weiner I, Lubow RE and Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology, 83, 194-199
46. Weiner I, Lubow RE and Feldon J (1988) Disruption of latent inhibition by acute administration of low dose of amphetamine. Pharmacology Biochemistry and Behavior, 30, 871-878.
47. Westerink BHC and DeVries JB (1988) Characterisation of in vivo dopamine release as determined by brain microdialysis after acute and chronic implantations: methodological aspects. Journal of Neurochemistry, 51, 683-687.
48. Westerink BHC, Hofsteede RM, Tuntler J and de Vries JB (1989) Use of calcium antagonism for the characterisation of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. Journal of Neurochemistry, 52, 722-729.
49. Wolf ME, White FJ, Nassar R, Brooderson RJ and Khansa MR (1993) Differential development of autoreceptor sensitivity and enhanced dopamine release during amphetamine sensitization. Journal of Pharmacology and Experimental Therapeutics, 264, 249-255.
50. Young AMJ, Joseph MH and Gray JA (1993) Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience, 54, 5-9.